Microsoft Azure Growth Forecast Beats Expectations Amid Rising AI Competition 
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement 
Berkshire Hathaway Q1 Earnings Jump 18% as Greg Abel Signals Disciplined Growth Strategy 
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook 
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance 
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand 
United Airlines Flight Hits Light Pole During Newark Landing, FAA Investigates 
SAN DIEGO, May 04, 2018 -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that it plans to release its first quarter 2018 financial results after the market closes on Thursday, May 10, 2018. The company will hold a conference call and simultaneous webcast at 5:00 PM, Eastern Time (2:00 PM Pacific Time) on Thursday, May 10, 2018 to discuss the company's financial results and provide a business update. Interested parties may access the conference call by dialing (844) 889-7791 (U.S.) or (661) 378-9934 (international) using passcode 3693617. Media and individuals will be in a listen-only mode. Participants are asked to dial in a few minutes prior to the call to register for the event. The conference call will also be webcast live at: https://edge.media-server.com/m6/p/q4jkh9dx.
An archive of the webcast will be available for twelve months following the event on the Obalon Therapeutics website located at http://investor.obalon.com in the “News & Events” section.
About Obalon Therapeutics, Inc.
Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit www.obalon.com.
For Obalon Therapeutics, Inc.
Investor Contact:
William Plovanic
Chief Financial Officer
Obalon Therapeutics, Inc.
Office: +1 760 607 5103
[email protected]
Media:
Megan Driscoll
EvolveMKD
Office Phone: +1 646 517 4220
[email protected]
